Yang DL, Ye L, Zeng FJ, Liu J, et al. Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermedi Hepatology 2025 Jan 15. doi: 10.1097/HEP.0000000000001229.
PMID: 39908184